Communicating cancer risk within an African context: Experiences, disclosure patterns and uptake rates following genetic testing for Lynch syndrome

Patient Education and Counseling

Volumn 92, Issue 1, 2013, Pages 53-60

  Bruwer, Zandrè ^a   Futter, Merle ^a   Ramesar, Raj ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Communication; Developing country; Genetic counselling; Lynch syndrome; Predictive testing; Qualitative

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RISK; CHILD; CONTROLLED STUDY; EMOTION; EXPERIENCE; FEMALE; GENETIC SCREENING; HEALTH BELIEF; HEALTH STATUS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INHERITANCE; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PATIENT EDUCATION; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SCHOOL CHILD; SEX DIFFERENCE; SOUTH AFRICA;

ADULT; AGED; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COMMUNICATION; COMPREHENSION; FAMILY RELATIONS; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SOUTH AFRICA; YOUNG ADULT;

EID: 84878630904     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2013.02.001     Document Type: Article

References (48)

1. Lynch H.T., de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003, 348:919-932.
2. Lynch H.T., Smyrk T., Lynch J.F. Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. Oncology 1998, 55:103-108.
3. Ramesar R.S., Madden M.V., Felix R., Harocopos C.J., Westbrook C.A., Jones G., et al. Molecular genetics improves the management of hereditary non-polyposis colorectal cancer. S Afr Med J 2000, 90:709-714.
4. Bruwer Z., Futter M., Ramesar R. Mobile colonoscopic unit for Lynch syndrome: trends in surveillance uptake and patient experiences of screening in a developing country. J Genet Couns 2012, 9523-9529. 10.1007/s10897-012-9523-9.
5. Evans J.P., Skrzynia C., Burke W. The complexities of predictive genetic testing. Brit Med J 2001, 322:1052-1056.
6. Järvinen H.J., Aarnio M., Mustonen H., Aktan-Collan K., Aaltonen L.A., Peltomaki P., et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000, 118:829-834.
7. Stoffel E.M., Ford B., Mercado R.C., Punglia D., Kohlmann W., Conrad P., et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008, 6:333-338.
8. Forrest K., Simpson S., Wilson B., van Teijlingen E., McKee L., Haites N., et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003, 64:317-326.
9. Gaff C.L., Collins V., Symes T., Halliday J. Facilitating family communication about predictive genetic testing: probands' perceptions. J Genet Counsl 2005, 14:133-140.
10. Graham E.E., Barbato C.A., Perse E.M. The interpersonal communication motives model. Commun Q 1993, 41:172-186.
11. Hughes C., Lerman C., Schwartz M., Peshkin B.N., Wenzel L., Narod S., et al. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002, 107:143-150.
12. Koehly L.M., Peterson S.K., Watts B.G., Kempf K.K.G., Vernon S.W., Gritz E.R. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidem Biomar 2003, 12:304-313.
13. McCann S., Macauley D., Barnett Y., Bunting B., Bradley A., Jeffers L., et al. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psychooncology 2009, 18:1208-1215.
14. Peterson S.K., Watts B.G., Koehly L.M., Vernon S.W., Baile W.F., Kohlmann W.K., et al. How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C: Semin Med Genet 2003, 119C:78-86.
15. Rubin R.B., Perse E.M., Barbato C.A. Conceptualization and measurement of interpersonal communication motives. Hum Commun Res 1988, 14:602-628.
16. Barbour R. Introducing qualitative research: a student guide to the craft of doing qualitative research 2008, Sage, London.
17. Brink H. Fundamentals of research methodology for health care professionals 1996, Juta and Company Ltd, Cape Town.
18. Rossouw D. Intellectual tools: skills for the human sciences 2003, Van Schaik, Cape Town. 2nd ed.
19. Stupart D.A., Goldberg P.A., Algar U., Ramesar R. Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation. Fam Cancer 2009, 8:519-523.
20. Ashida S., Hadley D.W., Vaughn B.K., Kuhn N.R., Jenkins J.F., Koehly L.M. The impact of familial environment on depression scores after genetic testing for cancer susceptibility. Clin Genet 2009, 75:43-49.
21. Bleiker E.M., Hahn D.E., Aaronson N.K. Psychosocial issues in cancer genetics-current status and future directions. Acta Oncol 2003, 42:276-286.
22. Esplen M.J., Madlensky L., Butler K., McKinnon W., Bapat B., Wong J., et al. Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 2001, 103:9-15.
23. Meiser B., Collins V., Warren R., Gaff C., St John D.J., Young M.A., et al. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 2004, 66:502-511.
24. Aktan-Collan K., Haukkala A., Mecklin J.P., Uutela A., Kaariainen H. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 2001, 93:608-611.
25. Claes E., Denayer L., Evers-Kiebooms G., Boogaerts A., Legius E. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 2004, 55:265-274.
26. Collins V., Meiser B., Ukoumunne O.C., Gaff C., St John D.J., Halliday J.L. The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med 2007, 9:290-297.
27. Esplen M.J., Madlensky L., Aronson M., Rothenmund H., Gallinger S., Butler K., et al. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet 2007, 72:394-401.
28. Mcallister M. Predictive genetic testing and beyond: a theory of engagement. J Health Psychol 2002, 7:491-508.
29. Green J., Richards M., Murton F., Statham H., Hallowell N. Family communication and genetic counselling: the case of hereditary breast and ovarian cancer. J Genet Counsel 1997, 6:45-60.
30. Mesters I., Ausems M., Eichhorn S., Vasen H. Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 2005, 4:163-167.
31. Bonadona V., Saltel P., Desseigne F., Mignotte H., Saurin J.C., Wang Q., et al. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidem Biomar 2002, 11:97-104.
32. Patenaude A.F., Dorval M., DiGianni L.S., Schneider K.A., Chittenden A., Garber J.E. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. J Clin Oncol 2006, 24:700-706.
33. Aktan-Collan K.I., Kaariainen H.A., Kolttola E.M., Pylvanainen K., Jarvinen H.J., Haukkala A.H., et al. Sharing genetic risk with next generation: mutation-positive parents' communication with their offspring in Lynch syndrome. Fam Cancer 2011, 10:43-50.
34. Ersig A.L., Hadley D.W., Koehly L.M. Colon cancer screening practices and disclosure after receipt of positive or inconclusive genetic test results for hereditary nonpolyposis colorectal cancer. Cancer 2009, 115:4071-4079.
35. Kohut K., Manno M., Gallinger S., Esplen M.J. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario familial colon cancer registry. Brit Med J 2007, 44:404-407.
36. Claes E., Evers-Kiebooms G., Boogaerts A., Decruyenaere M., Denayer L., Legius E. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet 2003, 116:11-19.
37. Kausmeyer D.T., Lengerich E.J., Kluhsman B.C., Morrone D., Harper G.R., Baker M.J. A survey of patients' experiences with the cancer genetic counselling process: recommendations for cancer genetics programs. J Genet Counsl 2006, 15:409-431.
38. Julian-Reynier C., Eisinger F., Chabal F., Lasset C., Nogues C., Stoppa-Lyonnet D., et al. Disclosure to the family of breast/ovarian cancer genetic test results: patient's willingness and associated factors. Am J Med Genet 2000, 94:13-18.
39. Lehmann L.S., Weeks J.C., Klar N., Biener L., Garber J.E. Disclosure of familial genetic information: perceptions of the duty to inform. Am J Med Genet 2000, 109:705-711.
40. Dugan R.B., Wiesner G.L., Juengst E.T., O'Riordan M., Matthews A.L., Robin N.H. Duty to warn at-risk relatives for genetic disease: genetic counselors' clinical experience. Am J Med Genet C: Semin Med Genet 2003, 119C:27-34.
41. Evans D.G., Binchy A., Shenton A., Hopwood P., Craufurd D. Coparison of proactive and usual approaches to offering predictive testing for BRCA1/2 mutations in unaffected relatives. Clin Genet 2009, 75:124-132.
42. Falk M.J., Dugan R.B., O'Riordan M.A., Matthews A.L., Robin N.H. Medical geneticists' duty to warn at-risk relatives for genetic disease. Am J Med Genet A 2003, 120A:374-380.
43. Segal J., Esplen M.J., Toner B., Baedorf S., Narod S., Butler K. An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers. Am J Med Genet A 2004, 125A:267-272.
44. Richards M. Families, kinship and genetics. The troubled helix: social and psychological implications of the new human genetics 1996, 249-273. Cambridge University Press, Cambridge. T. Marteau, M. Richards (Eds.).
45. Wilson B.J., Forrest K., van Teijlingen E.R., McKee L., Haites N., Matthews E., et al. Family communication about genetic risk: the little that is known. Commun Genet 2004, 7:15-24.
46. Croyle R.T., Lerman C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med 1993, 22:284-292.
47. Hadley D.W., Jenkins J., Dimond E., Nakahara K., Grogan L., Liewehr D.J., et al. Genetic counselling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 2003, 163:573-582.
48. Aktan-Collan K., Mecklin J.P., Jarvinen H., Nystrom-Lahti M., Peltomaki P., Soderling I., et al. Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 2000, 89:44-50.